定义并列出儿童期极罕见癌症:罕见癌症联合行动与欧洲儿童罕见肿瘤协作研究组的共识
欧盟罕见癌症联合行动(JARC)与欧洲儿童罕见肿瘤协作研究组合作,基于RARECAREnet数据库94个基于人群的癌症登记处和27个国家的数据,通过共识将儿童期极罕见癌症定义为年发病率<2/1000000的肿瘤,占0-14岁患者所有癌症的11%。共识识别出儿童期典型类型和成人期典型类型两个亚组,并认为2/1000000阈值也可用于0-19岁人群。
要点
- 极罕见儿童癌症定义为年发病率<2/1000000,占0-14岁患者所有癌症的11%。
- 共识识别出两个亚组:儿童期典型肿瘤(如肝母细胞瘤、胸膜肺母细胞瘤、胰母细胞瘤)和成人期典型肿瘤(如癌、黑色素瘤)。
- 2/1000000阈值也可用于0-19岁人群,此时甲状腺癌、睾丸癌和皮肤黑色素瘤发病率>2/1000000,但共识专家根据临床需求仍将其视为「极罕见」。
核心结论
- JARC共识产出了儿童期极罕见癌症的定义和列表,可能成为基于数据和患者临床需求优先研究这些肿瘤的起点。
研究设计与样本
- 欧洲联盟罕见癌症联合行动(JARC)推动的共识工作,与欧洲儿童罕见肿瘤协作研究组合作。
- 定义基于利用信息网络 on 罕见癌症(RARECAREnet)数据库估计的发病率,该数据库汇集了94个基于人群的癌症登记处和27个国家的数据。
- RARECAREnet癌症列表通过组合国际肿瘤学分类第三版形态学和拓扑学编码对癌症进行分组。
主要发现
- 根据共识,极罕见儿童癌症被确定为年发病率<2/1000000的肿瘤,占0-14岁患者所有癌症的11%。
- 识别出两个亚组:儿童期典型肿瘤类型(即肝母细胞瘤、胸膜肺母细胞瘤、胰母细胞瘤)和成人期典型肿瘤类型(即癌、黑色素瘤)。
- 2/1000000阈值也可用于0-19岁人群:此时有三种肿瘤类型的发病率>2/1000000(即甲状腺癌、睾丸癌和皮肤黑色素瘤),但共识专家根据其临床需求(如与其他罕见儿童癌症一样缺乏知识和临床专业知识)仍将其视为「极罕见」。
关键数值与推荐
- 极罕见儿童癌症定义为年发病率<2/1000000,占0-14岁患者所有癌症的11%。
- 0-19岁人群中,甲状腺癌、睾丸癌和皮肤黑色素瘤的发病率>2/1000000,但共识专家根据临床需求仍将其视为「极罕见」。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. The RARECAREnet list of cancers was used to estimate the incidence rates. This list groups cancers by combining the International Classification of Diseases for Oncology, third edition, morphology and topography codes. According to the consensus, very rare paediatric cancers were identified as those with an annual incidence <2/1000000 and corresponded to 11% of all cancers in patients aged 0-14 years. Two subgroups were identified: tumour types typical of childhood (i.e. hepatoblastoma, pleuropulmonary blastoma, pancreatoblastoma) and those typical of adult age (i.e. carcinomas, melanoma). The threshold of 2/1000000 could also be adopted in populations aged 0-19 years: in this case, three tumour types had an incidence rate which was >2/1000000 (i.e. thyroid and testicular cancers and skin melanoma), but the consensus experts considered them as 'very rare' according to their clinical needs (e.g. shortage of knowledge and clinical expertise as the other rare paediatric cancers). The JARC consensus produced a definition and a list of very rare paediatric cancers which may represent a starting point for prioritising research on these tumours, based on data and patients' clinical needs.
引用
- Ferrari A, Brecht IB, Gatta G, et al. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer. 2019. PMID: 30785015. doi:10.1016/j.ejca.2018.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。